NASDAQ: AZR
Azora Therapeutics Inc Stock Ownership - Who owns Azora Therapeutics?

Insider buying vs selling

Have Azora Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Coastlands Capital LP10% Owner2026-07-161,233$2.75
$3.39kBuy
Coastlands Capital LP10% Owner2026-07-142,000$2.65
$5.30kBuy
Coastlands Capital LP10% Owner2026-07-101,700$2.70
$4.59kBuy
Coastlands Capital LP10% Owner2026-07-0910,053$2.79
$28.05kBuy
Coastlands Capital LP10% Owner2026-06-2925,000$2.60
$65.00kBuy

1 of 1

AZR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AZR insiders and whales buy or sell their stock.

AZR Shareholders

What type of owners hold Azora Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
William B. Stilley Iii53.08%1,393,920$6.80MInsider
Bankole A. Johnson33.24%872,720$4.26MInsider
James W. Newman Jr.16.71%438,742$2.14MInsider
Coastlands Capital LP14.79%388,308$1.89MInsider
Matt Davidson11.40%299,414$1.46MInsider
Joseph Truluck10.10%265,139$1.29MInsider
Robertson H. Gilliland4.52%118,609$578.81kInsider
Cary J. Claiborne1.54%40,417$197.23kInsider
Tony Goodman1.01%26,523$129.43kInsider
Vinay Shah0.66%17,325$84.55kInsider

1 of 3

AZR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AZR0.00%100.00%Net Buying
KAPA0.00%32.08%
LPCN0.04%90.96%Net BuyingNet Buying
DYAI0.01%99.99%Net Selling
GUTS0.24%99.76%Net BuyingNet Buying

Azora Therapeutics Stock Ownership FAQ

Who owns Azora Therapeutics?

Azora Therapeutics (NASDAQ: AZR) is owned by 0.01% institutional shareholders, 147.52% Azora Therapeutics insiders, and 0.00% retail investors. William B. Stilley Iii is the largest individual Azora Therapeutics shareholder, owning 1.39M shares representing 53.08% of the company. William B. Stilley Iii's Azora Therapeutics shares are currently valued at $6.80M.

If you're new to stock investing, here's how to buy Azora Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.